Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ciaftalan SCHEMBL15816 | 1.00 | MEN1 (0.46) | MEN1KMT2ATDP1RECQLTHRB | |
| Ciaftalan SCHEMBL29360952 | 1.00 | MEN1 (0.46) | MEN1KMT2ATDP1RECQLTHRB | |
| Ciaftalan SCHEMBL5795179 | 1.00 | MEN1 (0.46) | MEN1KMT2ATDP1RECQLTHRB | |
| SCHEMBL813083 | 1.00 | MEN1 (0.46) | MEN1KMT2ATDP1RECQLTHRB | |
| Ciaftalan SCHEMBL1728179 | 1.00 | MEN1 (0.46) | MEN1KMT2ATDP1RECQLTHRB | |
| Ciaftalan SCHEMBL3199060 | 0.98 | MEN1 (0.45) | MEN1KMT2ATDP1RECQLTHRB | |
| Ciaftalan SCHEMBL11430027 | 0.98 | MEN1 (0.45) | MEN1KMT2ATDP1RECQLTHRB | |
| Ciaftalan SCHEMBL6550047 | 0.98 | MEN1 (0.45) | MEN1KMT2ATDP1RECQLTHRB | |
| Ciaftalan SCHEMBL15992891 | 0.98 | MEN1 (0.45) | MEN1KMT2ATDP1RECQLTHRB | |
| Ciaftalan SCHEMBL22471714 | 0.98 | MEN1 (0.45) | MEN1KMT2ATDP1RECQLTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606715-B2 | Aqueous ink composition for writing instruments | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2026-04-21 | — | — | US | claimed |
| EP-3768502-B1 | INK COMPOSITION FOR COSMETIC CONTACT LENSES | JOHNSON & JOHNSON VISION CARE (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4525655-B1 | METHOD FOR THE MANUFACTURE OF ELECTRICALLY INSULATING PROTECTIVE GLOVES WITH ARC PROTECTION AND SUCH PROTECTIVE GLOVES | JUNG GUMMITECHNIK GMBH (DE) | 2026-04-01 | — | — | EP | claimed |
| EP-4617327-A1 | POLYMERIC DYES WITH ENHANCED BIODEGRADABILITY CONTAINING SACCHARIDE OR POLYSACCHARIDE BUILDING BLOCKS | Heubach Holding Switzerland AG (Ltd) (CH) | 2025-09-17 | — | — | EP | claimed |
| WO-2025133314-A1 | POLYMERIC DYES WITH ENHANCED BIODEGRADABILITY CONTAINING POLYCARBOXYLIC ACIDS, AMINO ACIDS, POLYAMINO ACIDS AND/OR PEPTIDE BUILDING BLOCKS | HEUBACH HOLDING SWITZERLAND AG (LTD) (CH) | 2025-06-26 | — | — | WO | claimed |
| EP-3934594-B1 | ENERGY AUGMENTATION STRUCTURES FOR USE IN NON-INVASIVE IN-SITU PHOTOBIOMODULATION | IMMUNOLIGHT LLC (US) | 2025-05-28 | — | — | EP | claimed |
| CN-119529299-A | Phthalocyanine-based MOF nano material, preparation method and antibacterial application thereof | 上海大学 | 2025-02-28 | — | — | CN | claimed |
| US-12178886-B2 | Imaging and treatment of pathophysiologic conditions by Cerenkov radiation | WASHINGTON UNIVERSITY (US) | 2024-12-31 | — | — | US | claimed |
| EP-3934807-B1 | DYE-BASED LIQUID REAGENT VOLUME INDICATOR FOR USE IN ANALYTE DETECTION ASSAYS | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2024-12-25 | — | — | EP | claimed |
| CN-119108439-A | Hot carrier solar cell and preparation method thereof | 浙江爱旭太阳能科技有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-114914449-A | Polymer composite nano material, preparation method thereof and sulfide all-solid-state battery | 上海屹锂新能源科技有限公司 | 2022-08-16 | — | — | CN | claimed |
| WO-2022155385-A1 | METHODS AND COMPOSITIONS FOR VISUALIZING A URETER IN A SURGICAL PROCEDURE | ALUME BIOSCIENCES, INC. (US) | 2022-07-21 | — | — | WO | claimed |
| WO-2022136403-A1 | USE OF REACTIVE PROTEIN CROSS-LINKING AGENTS FOR CROSSLINKING PROTEIN-CONTAINING SUBSTRATES AND PROCESSES FOR TANNING AND DYEING OF LEATHER | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2022-06-30 | — | — | WO | claimed |
| US-20220202961-A1 | IMAGING AND TREATMENT OF PATHOPHYSIOLOGIC CONDITIONS BY CERENKOV RADIATION | WASHINGTON UNIVERSITY | 2022-06-30 | — | — | US | claimed |
| WO-2022120177-A1 | NERVE TARGETING PEPTIDES AND METHODS OF USE | ALUME BIOSCIENCES, INC. (US) | 2022-06-09 | — | — | WO | claimed |
| US-11299515-B2 | Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-12 | — | — | US | claimed |
| US-20220096862-A1 | METHOD FOR IRRADIATING CELLS WITH LIGHT, METHOD FOR CONTROLLING MEDICAL DEVICE, AND MEDICAL DEVICE | OLYMPUS CORPORATION (JP) | 2022-03-31 | — | — | US | claimed |
| EP-3183037-B1 | COMPOSITIONS FOR SELECTIVE ACTIVATION OF PHOTOREACTIVE RESPONSES | IMMUNOLIGHT LLC (US) | 2022-03-16 | — | — | EP | claimed |
| US-20220069281-A1 | GRAPHENE-INFILTRATED POROUS ANODE ACTIVE MATERIAL PARTICLES FOR RECHARGEABLE LITHIUM BATTERIES | HONEYCOMB BATTERY COMPANY | 2022-03-03 | — | — | US | claimed |
| WO-2022018288-A2 | POLYMER COMPOSITION FOR MOULDED ARTICLE | BOREALIS AG (AT) | 2022-01-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606715-B2 | Aqueous ink composition for writing instruments | UTP18, PUF60, EXOSC10 | MEN1 4245/4885KMT2A 541/4885TDP1 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.